Trademark: 79364819
Word
DBV TECHNOLOGIES
Status Date
Tuesday, May 21, 2024
Registration Number
7390033
Registration Date
Tuesday, May 21, 2024
Filing Date
Monday, September 19, 2022
Published for Opposition
Tuesday, March 5, 2024
41 Educational services for consumers and professionals in the field of immunotherapy, namely, organizing classes, seminars, programs, conferences, congresses, workshops in the field of immunotherapy; organizing and providing exhibitions for online educational purposes featuring interactive presentations and exhibitions in the field of immunotherapy; publishing periodicals, books, and guides in the field of immunotherapy; database publishing services, namely publishing of periodical journals containing printed databases in tabular form in the field of immunotherapy; providing information with respect to education in the field of immunotherapy via an online website
5 Medicated adhesive devices in the nature of epicutaneous patches enabling the cutaneous or epicutaneous administration of pharmaceutical or medicated substances in dry form for humans and animals for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases; epicutaneous patches containing powdered preparations for medical use for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases; medicated occlusion patches in the nature of epicutaneous patches enabling the absorption of powdered medicated substances through the skin for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases
44 Medical services using desensitization methods on the principle of immunotherapy; medical treatment and prevention of allergies, inflammatory, autoimmune and infectious diseases through the administration of allergens, antigens using patches affixed to the patients' unbroken skin, thus avoiding the transfer of allergens into the blood; medical treatment and prevention of allergies, inflammatory, autoimmune and infectious diseases using epicutaneous methods of desensitization via immunotherapy; epicutaneous medical treatments and prevention of allergies, inflammatory, autoimmune and infectious diseases without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact; medical consultancy in the field of desensitization to allergies with respect to desensitization to combat allergies
10 Medical apparatus, instruments and devices, namely, epicutaneous patches sold without medication for the cutaneous or epicutaneous administration of medicated or cosmetic substances in dry form for humans or animals; occlusion patch dispensers for medical use; medical instruments using the electrostatic properties of biocompatible media, namely, epicutaneous patches sold without medication
42 Medical and scientific research in the field of immunotherapy, namely, developing scientific methods for epicutaneous immunotherapy, to try to treat and prevent autoimmune, infectious and inflammatory diseases without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact; scientific research in the field of allergy treatment and care; scientific research in the field of allergy treatment for the repeated application of treatments to patients' skin without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact and thus avoid the passage of allergens into the blood; allergenic drug discovery services; medical and scientific research services, namely, developing methods for treating allergies via contact between allergens and skin immune cells; medical and scientific research services, namely, developing methods for the treatment and prevention of allergies, autoimmune, infectious and inflammatory diseases by applying patches to patients' unbroken skin without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact
Mar 9, 2023
Sn Assigned For Sect 66a Appl From Ib
Mar 17, 2023
New Application Office Supplied Data Entered
Mar 21, 2023
Application Filing Receipt Mailed
Jun 29, 2023
Assigned To Examiner
Jul 4, 2023
Non-Final Action Written
Jul 5, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Aug 9, 2023
Refusal Processed By Mpu
Aug 9, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Aug 29, 2023
Refusal Processed By Ib
Jan 24, 2024
Teas Response To Office Action Received
Jan 24, 2024
Correspondence Received In Law Office
Jan 24, 2024
Teas/Email Correspondence Entered
Feb 14, 2024
Notification Of Possible Opposition Sent To Ib
Feb 14, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 14, 2024
Notification Of Notice Of Publication E-Mailed
Feb 14, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 5, 2024
Published For Opposition
Mar 5, 2024
Official Gazette Publication Confirmation E-Mailed
May 21, 2024
Registered-Principal Register
May 21, 2024
Notice Of Registration Confirmation Emailed
Jan 26, 2024
Approved For Pub - Principal Register
Mar 4, 2024
Notification Processed By Ib
Trademark Alertz updated from USPTO on 2030-01-24
